ArticleMDM policy & practice

Real-World Cost-Effectiveness of Bevacizumab With First-Line Combination Chemotherapy in Patients With Metastatic Colorectal Cancer: Population-Based Retrospective Cohort Studies in Three Canadian Provinces.

Reka E Pataky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.